As of November 6, 2026, Arvinas, Inc. is a publicly traded company (Nasdaq: ARVN); its largest reported holder is Vanguard, with 6.12% on Schedule 13G of April 28, 2026, then D. E. Shaw & Co., L.P. (5.4%). The largest insider holding is John G. Houston, a director, with 1,122,183 shares (1.7% of shares outstanding), per Form 4 of March 2, 2026 (Schedule 13G, April 28, 2026).
Is this your company?
About to sign with, pay or invest in Arvinas, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Arvinas, Inc. a real, registered company?
- Arvinas, Inc. files with the SEC under CIK 1655759 (its SEC filings).
- Its shares are listed under the ticker ARVN on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in New Haven, Connecticut, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Arvinas, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names D. E. Shaw & Co., L.P. (filed 2026-08-14).
Who are Arvinas, Inc.'s owners and officers?
Arvinas, Inc.: incorporated in Delaware; business address in New Haven, Connecticut; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | D. E. Shaw & Co., L.P. | 5.4% |
| Schedule 13G, 2026-04-28 | Vanguard Portfolio Management | 6.12% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G, 2025-11-14 | D. E. Shaw & Co., L.P. | 5.3% |
| Schedule 13G/A, 2025-11-14 | Kenneth Griffin | 0.4% |
| Schedule 13D/A, 2025-10-15 | Logos Global Management LP | 3.4% |
| Schedule 13D/A, 2025-08-22 | Logos Global Management LP | 8.6% |
| Schedule 13G/A, 2025-08-14 | T. Rowe Price Associates, Inc. | 1.9% |
Questions about who owns Arvinas, Inc.
Who owns Arvinas, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Arvinas, Inc.: Vanguard Portfolio Management (6.12%, Schedule 13G, filed 2026-04-28) and D. E. Shaw & Co., L.P. (5.4%, Schedule 13G/A, filed 2026-08-14).
Who are the largest shareholders of Arvinas, Inc.?
By the share each holder's latest filing reports, the largest holders of Arvinas, Inc. on this page are Vanguard Portfolio Management (6.12%) and D. E. Shaw & Co., L.P. (5.4%).
When did Vanguard Portfolio Management buy into Arvinas, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Vanguard Portfolio Management on this page is the Schedule 13G, filed 2026-04-28, reporting 6.12%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Arvinas, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Arvinas, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Arvinas, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Arvinas, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 1,122,183 shares (1.7% of shares outstanding) (Form 4, 2026-03-02).
- , the chief executive and president: 285,009 shares (0.44% of shares outstanding) (Form 4, 2026-05-22).
- , the chief medical officer: 191,395 shares (0.29% of shares outstanding) (Form 4, 2026-05-13).
- , the chief financial officer: 187,432 shares (0.29% of shares outstanding) (Form 4, 2026-06-24).
- , the chief scientific officer: 180,390 shares (0.28% of shares outstanding) (Form 4, 2026-06-18).
Shares outstanding: 65,485,006 as of 2026-10-30, from the company's latest SEC cover page.
How much has Arvinas, Inc. raised?
No fundraising or offering filing from Arvinas, Inc. is on file with us.
Keep reading
More on Arvinas, Inc. and the records around it.
Arvinas, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Logos Global Management LP also filed stake reports on 14 other companies: Longeveron Inc. (Sep 2026), ACHIEVE LIFE SCIENCES, INC. (Aug 2026), Yarrow Bioscience, Inc. (Aug 2026)
- D. E. Shaw & Co., L.P. also filed stake reports on 28 other companies: Gossamer Bio, Inc. (Oct 2026), Sweetgreen, Inc. (Oct 2026), Venture Global, Inc. (Sep 2026)
- Citadel Advisors LLC also filed stake reports on 58 other companies: Quantinuum Inc. (Oct 2026), REALLOYS INC. (Oct 2026), STARFIGHTERS SPACE, INC. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/arvinas